News
Company News
Industry Insights
Industry Insights
Home > News
-
Applications of Immunity-Enhancing Akkermansia muciniphila Akk007 in Health ProductsThis patent delves into the detailed examination of the Akkermansia muciniphila Akk007, a probiotic with significant immunomodulatory properties.August 19 MORE > -
Nature Confirms: Akkermansia Muciniphila (Akk) Boosts Metabolic Health by 42.42%Recent groundbreaking research published in Nature Microbiology has highlighted the significant role of Akkermansia muciniphila (Akk) in combating metabolic disorders.August 16 MORE > -
The Power of Akkermansia muciniphila: A Game-Changer in ProbioticsIn the world of probiotics, Akkermansia muciniphila is emerging as a revolutionary player with promising potential for enhancing gut health and aiding in weight management.August 15 MORE > -
WecStrain™ Limosilactobacillus reuteri LR38 for Alleviating Polycystic Ovary Syndrome and Its ApplicationThe patent describes the discovery and application of a specific strain of Limosilactobacillus reuteri (LR38), preserved under CGMCC No.24408, which is effective in improving polycystic ovary syndrome (PCOS).August 09 MORE > -
Discover The Vital Role of Human-Residential Probiotics During World Breastfeeding Week: Bifidobacterium Animalis subsp. Lactis BLa80 in Gastrointestinal HealthHuman-residential probiotics are beneficial microorganisms that naturally reside in the human body, particularly in the gut. They play a crucial role in maintaining health and well-being.August 06 MORE > -
Clinical trial of WecLac® Weizmannia coagulans BC99 in Alleviating Chronic ConstipationWeizmannia coagulans BC99, a novel probiotic strain, has shown potential in treating gastrointestinal disorders, particularly chronic constipation.July 29 MORE >
No. 1033 Longqiao Road, Wujiang Economic and Technological Development Zone, Jiangsu Province, China
Leave a Message
Email
Linkedin